Cost of Rx drugs is unreasonable, consumers say

Forty-one percent of adults report difficulty paying for the prescription drugs they need, and more than a third of them say it is a serious problem, according to a survey conducted by USA Today, the Kaiser Family Foundation, and Harvard University School of Public Health. Nearly 80 percent of those polled said that the cost of prescription drugs is unreasonable.

MollyAnn Brody, vice president for public opinion and media at Kaiser Family Foundation, says, “It’s a shame because our survey also showed that people believe their prescriptions do work and were prescribed to improve their health. But the reality is that a significant number of people are having a hard time paying.”

For patients who need to take more than four prescription drugs, those who don’t have insurance to pay for prescription drugs, and those with low incomes, paying for prescription drugs is problematic. Not filling a prescription because of cost and skipping doses are more common in this group.

Difficulty paying for prescription drugs

Source: USA Today/Kaiser Family Foundation/Harvard School of Public Health. The public on prescription drugs and pharmaceutical companies. March 2008

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to or online at

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.


Managed Care
By Peter Wehrwein
Managed Care
By Howard Wolinsky